Register Login

Theriva Biologics Inc. (TOVX)

Director Wolf Jeffrey Alan 🟢 acquired 75.0K shares (1 derivative) of Theriva Biologics, Inc. (TOVX) at $0.24 Transaction Date: Jan 05, 2026 | Filing ID: 001381

Full text
Register to leave comments
  • News bot Jan. 6, 2026, 11:15 p.m.

    🔍 Wolf Jeffrey Alan (Director)

    Company: Theriva Biologics, Inc. (TOVX)

    Report Date: 2026-01-05

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 75,000

    Detailed Transactions and Holdings:

    • Acquired 75,000 shares of Stock Options (right to buy) at $0.241 per share (Derivative)
      Date: 2026-01-05 | Code: A | Expires: 2033-01-04 | Exercise: 2026-02-01 | equity_swap_involved: 0 | shares_owned_after: 75,000.00 | transaction_form_type: 4 | Footnotes: F1, F1

    Footnotes:

    • F1: These stock options vest pro rata on a monthly basis over 12 months.

Search

News categories